Westlake reports Q3 EPS (29c), consensus (23c)

Reports Q3 revenue $2.84B, consensus $2.95B. “Global macroeconomic conditions remained challenging throughout the third quarter of 2025 with continued weakness in industrial and manufacturing activity putting pressure on sales prices and margins in our PEM segment, particularly for chlorovinyls. As a result, during the third quarter we recorded a non-cash impairment charge of $727 million for all of the goodwill associated with PEM’s North American Chlorovinyls business. We remain committed to this business as the global need for its products, which are critical to industries ranging from building materials to water to manufacturing, remains intact. We have taken actions to reduce costs to deliver the earnings it is capable of generating and we will assess opportunities to optimize its footprint to return it to levels of profitability that provide an appropriate return on investment,” said Jean-Marc Gilson, President and Chief Executive Officer.